Trial
NCT02496832
A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
Merck Frosst Canada Ltd.
Condition
Pancreatic Adenocarcinoma
Intervention
18F-Fluoroazomycin arabinoside
Why stopped
Study was never initiated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-19